Subcellular proteomic analysis of human host cells infected with H3N2 swine influenza virus

Proteomics

Volumn 13, Issue 22, 2013, Pages 3309-3326

  Wu, Xiaopeng ^a,b   Wang, Sanying ^a,b   Yu, Yang ^a,b   Zhang, Jinyang ^a,b   Sun, Zeyu ^a   Yan, Yan ^a,b   Zhou, Jiyong ^a,b,c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

2DE; A549 cells; Interaction; Microbiology; Subcellular proteomics; Swine influenza

Indexed keywords

CYTOPLASM PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; NONSTRUCTURAL PROTEIN 1; TRYPTOPHAN TRANSFER RNA LIGASE; PROTEIN; PROTEOME; TRANSCRIPTOME;

ARTICLE; AUTOLYSIS; CELL CULTURE; CELL DEATH; CELL FRACTIONATION; DOWN REGULATION; HOST CELL; IMAGE ANALYSIS; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; UPREGULATION; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; CLASSIFICATION; CONFOCAL MICROSCOPY; HOST PATHOGEN INTERACTION; HUMAN; INTRACELLULAR SPACE; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIROLOGY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL LINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INTRACELLULAR SPACE; MASS SPECTROMETRY; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; PROTEINS; PROTEOME; TRANSCRIPTOME;

EID: 84888058998     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300180     Document Type: Article

References (65)

1. Lemon, S. M., Mahmoud, A. A., The threat of pandemic influenza: are we ready? Biosecur. Bioterror. 2005, 3, 70-73.
2. Vijaykrishna, D., Smith, G. J., Pybus, O. G., Zhu, H. et al., Long-term evolution and transmission dynamics of swine influenza A virus. Nature 2011, 473, 519-522.
3. Horimoto, T., Kawaoka, Y., Influenza: lessons from past pandemics, warnings from current incidents. Nat. Rev. Microbiol. 2005, 3, 591-600.
4. Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F. et al., The impact of influenza epidemics on mortality: introducing a severity index. Am. J. Public Health 1997, 87, 1944-1950.
5. Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L. et al., Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289, 179-186.
6. Wang, T. T., Palese, P., Unraveling the mystery of swine influenza virus. Cell 2009, 137, 983-985.
7. Shapira, S. D., Gat-Viks, I., Shum, B. O., Dricot, A. et al., A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139, 1255-1267.
8. Olsen, C. W., The emergence of novel swine influenza viruses in North America. Virus Res. 2002, 85, 199-210.
9. Liu, N., Song, W., Wang, P., Lee, K. et al., Proteomics analysis of differential expression of cellular proteins in response to avian H9N2 virus infection in human cells. Proteomics 2008, 8, 1851-1858.
10. Coombs, K. M., Berard, A., Xu, W., Krokhin, O. et al., Quantitative proteomic analyses of influenza virus-infected cultured human lung cells. J. Virol. 2010, 84, 10888-10906.
11. Vester, D., Rapp, E., Gade, D., Genzel, Y., Reichl, U., Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics 2009, 9, 3316-3327.
12. Baas, T., Baskin, C. R., Diamond, D. L., Garcia-Sastre, A. et al., Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol. 2006, 80, 10813-10828.
13. Vester, D., Rapp, E., Kluge, S., Genzel, Y., Reichl, U., Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach. J. Proteomics 2010, 73, 1656-1669.
14. Brasier, A. R., Spratt, H., Wu, Z., Boldogh, I. et al., Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J. Virol. 2004, 78, 11461-11476.
15. Ohman, T., Rintahaka, J., Kalkkinen, N., Matikainen, S., Nyman, T. A., Actin and RIG-I/MAVS signaling components translocate to mitochondria upon influenza A virus infection of human primary macrophages. J. Immunol. 2009, 182, 5682-5692.
16. Lam, Y. W., Evans, V. C., Heesom, K. J., Lamond, A. I., Matthews, D. A., Proteomics analysis of the nucleolus in adenovirus-infected cells. Mol. Cell. Proteomics 2010, 9, 117-130.
17. Emmott, E., Rodgers, M. A., Macdonald, A., McCrory, S. et al., Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus. Mol. Cell. Proteomics 2010, 9, 1920-1936.
18. Emmott, E., Wise, H., Loucaides, E. M., Matthews, D. A. et al., Quantitative proteomics using SILAC coupled to LC-MS/MS reveals changes in the nucleolar proteome in influenza A virus-infected cells. J. Proteome Res. 2010, 9, 5335-5345.
19. Zheng, X. J., Hong, L. L., Shi, L. X., Guo, J. Q. et al., Proteomics analysis of host cells infected with infectious bursal disease virus. Mol. Cell. Proteomics 2008, 7, 612-625.
20. Yan, J. X., Wait, R., Berkelman, T., Harry, R. A. et al., A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21, 3666-3672.
21. Taylor, C. F., Paton, N. W., Lilley, K. S., Binz, P. A. et al., The minimum information about a proteomics experiment (MIAPE). Nat. Biotechnol. 2007, 25, 887-893.
22. Munday, D. C., Emmott, E., Surtees, R., Lardeau, C. H. et al., Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Mol. Cell. Proteomics 2010, 9, 2438-2459.
23. Shetty, S., Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells. Mol. Cell. Biochem 2005, 272, 107-118.
24. Kiledjian, M., Dreyfuss, G., Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. EMBO J. 1992, 11, 2655-2664.
25. Kisselev, L., Frolova, L., Haenni, A. L., Interferon inducibility of mammalian tryptophanyl-tRNA synthetase: new perspectives. Trends Biochem. Sci. 1993, 18, 263-267.
26. Durfee, L. A., Lyon, N., Seo, K., Huibregtse, J. M., The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol. Cell 2010, 38, 722-732.
27. Haller, O., Kochs, G., Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 2002, 3, 710-717.
28. Christian, K. J., Lang, M. A., Raffalli-Mathieu, F., Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment. Mol. Pharmacol. 2008, 73, 1558-1567.
29. Mincberg, M., Gopas, J., Tal, J., Minute virus of mice (MVMp) infection and NS1 expression induce p53 independent apoptosis in transformed rat fibroblast cells. Virology 2011, 412, 233-243.
30. Maxwell, K. L., Frappier, L., Viral proteomics. Microbiol. Mol. Biol. Rev. 2007, 71, 398-411.
31. Gustin, K. E., Sarnow, P., Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J. 2001, 20, 240-249.
32. Gupta, A. K., Drazba, J. A., Banerjee, A. K., Specific interaction of heterogeneous nuclear ribonucleoprotein particle U with the leader RNA sequence of vesicular stomatitis virus. J. Virol. 1998, 72, 8532-8540.
33. Hale, B. G., Randall, R. E., Ortin, J., Jackson, D., The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 2008, 89, 2359-2376.
34. Melen, K., Kinnunen, L., Fagerlund, R., Ikonen, N. et al., Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J. Virol. 2007, 81, 5995-6006.
35. Volmer, R., Mazel-Sanchez, B., Volmer, C., Soubies, S. M., Guerin, J. L., Nucleolar localization of influenza A NS1: striking differences between mammalian and avian cells. Virol. J. 2010, 7, 63.
36. Lee, J. H., Kim, S. H., Pascua, P. N., Song, M. S. et al., Direct interaction of cellular hnRNP-F and NS1 of influenza A virus accelerates viral replication by modulation of viral transcriptional activity and host gene expression. Virology 2010, 397, 89-99.
37. Gorlach, M., Burd, C. G., Dreyfuss, G., The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins. J. Biol. Chem. 1994, 269, 23074-23078.
38. Gustin, K. E., Sarnow, P., Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J. Virol. 2002, 76, 8787-8796.
39. Spahn, A., Blondeau, N., Heurteaux, C., Dehghani, F., Rami, A., Concomitant transitory up-regulation of X-linked inhibitor of apoptosis protein (XIAP) and the heterogeneous nuclear ribonucleoprotein C1-C2 in surviving cells during neuronal apoptosis. Neurochem. Res. 2008, 33, 1859-1868.
40. Noisakran, S., Sengsai, S., Thongboonkerd, V., Kanlaya, R. et al., Identification of human hnRNP C1/C2 as a dengue virus NS1-interacting protein. Biochem. Biophys. Res. Commun. 2008, 372, 67-72.
41. Munday, D. C., Hiscox, J. A., Barr, J. N., Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus subgroup B using SILAC coupled to LC-MS/MS. Proteomics 2010, 10, 4320-4334.
42. Piccoli, C., Scrima, R., D'Aprile, A., Ripoli, M. et al., Mitochondrial dysfunction in hepatitis C virus infection. Biochim. Biophys. Acta 2006, 1757, 1429-1437.
43. Grills, C., Jithesh, P. V., Blayney, J., Zhang, S. D., Fennell, D. A., Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer. PLoS One 2011, 6, e14635.
44. Moore, C. B., Bergstralh, D. T., Duncan, J. A., Lei, Y. et al., NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451, 573-577.
45. Arrigo, A. P., Structure-functions of HspB1 (Hsp27). Methods Mol. Biol. 2011, 787, 105-119.
46. Mosser, D. D., Morimoto, R. I., Molecular chaperones and the stress of oncogenesis. Oncogene 2004, 23, 2907-2918.
47. Alfonso, P., Rivera, J., Hernaez, B., Alonso, C., Escribano, J. M., Identification of cellular proteins modified in response to African swine fever virus infection by proteomics. Proteomics 2004, 4, 2037-2046.
48. Leong, W. F., Chow, V. T., Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection. Cell. Microbiol. 2006, 8, 565-580.
49. Tan, J., Qiao, W., Wang, J., Xu, F. et al., IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus. J. Virol. 2008, 82, 4275-4283.
50. Davila, S., Froeling, F. E., Tan, A., Bonnard, C. et al., New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun. 2010, 11, 232-238.
51. Zhang, L., Tang, Y., Tie, Y., Tian, C. et al., The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling. Cell. Signal. 2007, 19, 932-944.
52. Fillmore, R. A., Mitra, A., Xi, Y., Ju, J. et al., Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int. J. Cancer 2009, 125, 556-564.
53. Lee, N. D., Chen, J., Shpall, R. L., Naumovski, L., Subcellular localization of interferon-inducible Myc/stat-interacting protein Nmi is regulated by a novel IFP 35 homologous domain. J. Interferon Cytokine Res. 1999, 19, 1245-1252.
54. Zhou, X., Liao, J., Meyerdierks, A., Feng, L. et al., Interferon-alpha induces nmi-IFP35 heterodimeric complex formation that is affected by the phosphorylation of IFP35. J. Biol. Chem. 2000, 275, 21364-21371.
55. Narasimhan, J., Wang, M., Fu, Z., Klein, J. M. et al., Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J. Biol. Chem. 2005, 280, 27356-27365.
56. Kim, K. I., Giannakopoulos, N. V., Virgin, H. W., Zhang, D. E., Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol. Cell. Biol. 2004, 24, 9592-9600.
57. Billharz, R., Zeng, H., Proll, S. C., Korth, M. J. et al., The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J. Virol. 2009, 83, 10557-10570.
58. Safronetz, D., Rockx, B., Feldmann, F., Belisle, S. E. et al., Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J. Virol. 2011, 85, 1214-1223.
59. Ma, W., Belisle, S. E., Mosier, D., Li, X. et al., 2009 pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs. J. Virol. 2011, 85, 11626-11637.
60. Chan, R. B., Tanner, L., Wenk, M. R., Implications for lipids during replication of enveloped viruses. Chem. Phys. Lipids 2010, 163, 449-459.
61. Heaton, N. S., Randall, G., Multifaceted roles for lipids in viral infection. Trends Microbiol. 2011, 19, 368-375.
62. Xiao, T., Shoeb, M., Siddiqui, M. S., Zhang, M. et al., Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes. J. Toxicol. Environ. Health A 2009, 72, 577-584.
63. Martinelli, E., Tharinger, H., Frank, I., Arthos, J. et al., HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog. 2011, 7, e1002109.
64. Kalinec, F., Webster, P., Maricle, A., Guerrero, D. et al., Glucocorticoid-stimulated, transcription-independent release of annexin A1 by cochlear Hensen cells. Br. J. Pharmacol. 2009, 158, 1820-1834.
65. Kamal, A. M., Smith, S. F., De Silva Wijayasinghe, M., Solito, E., Corrigan, C. J., An annexin 1 (ANXA1)-derived peptide inhibits prototype antigen-driven human T cell Th1 and Th2 responses in vitro. Clin. Exp. Allergy 2001, 31, 1116-1125.